Dr. Vladimir Cmiljanovic
Chief Executive Officer
Dr. Vladimir Cmiljanovic, Chief Executive Officer and Founder, is one of Switzerland's leading serial pharma entrepreneurs, a medicinal chemist, and a cancer scientist with more than fifteen years of experience in oncology drug development. He is co-author of numerous scientific articles and abstracts and inventor of several patent families with more than 400 registered patents.
Dr. Natasa Cmiljanovic
Chief Scientific Officer
Dr. Natasa Cmiljanovic, Chief Scientific Officer and Founder, is a medicinal chemist and clinical scientist with more than ten years of experience in oncology drug development. She is the co-author of various scientific articles and abstracts and inventor of numerous patents.
Dr. Josef Künzle
Chief Quality Officer
Dr. Josef Künzle, Chief Quality Officer, joined Swiss Rockets as Chief Quality Officer after taking early retirement from Basilea in 2018, where he was Head of Global Quality Management in the independent Quality Unit, and as a member of the Extended Management Team since August 2015. He joined Basilea in 2007 as a Quality Assurance Project Manager.
Chief Legal and Corporate Development Officer
Saif Al-Rubai, Chief Legal and Corporate Development Officer, received his law degree in 2009 and was admitted to the bar of Basel-Country in 2012. As an experienced lawyer and trusted deputy to a law firm partner, he has successfully designed, developed, and implemented legal case strategies and tactics in a variety of legal fields for the last seven years, including several Swiss Federal Court cases.
Albert Muntane Casanova
Chief Financial Officer
Albert Muntane Casanova, Chief Financial Officer, joined Swiss Rockets from Mitsubishi UFJ Financial Group (MUFG Bank), where he was Director Investment Banking in the global aviation finance office, formerly the Aviation Division of DVB Bank SE, based in London. During this 5-year period, his responsibilities included advising airlines and lessors on raising finance as well as on strategy.